There were 859 citations for “Mesenchymal stem cell-derived microvesicles protect against acute tubular injury”, followed by “Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury”, with 666 citations. Here, AKT1 is linked to myocardial ischemia.